Combined effect of an ACE inhibitor, perindopril, and interferon on liver fibrosis markers in patients with chronic hepatitis C

被引：0
|
作者：
Hitoshi Yoshiji
Ryuichi Noguchi
Hiroshi Fukui
机构：
[1] Nara Medical University,Third Department of Internal Medicine
来源：
Journal of Gastroenterology | 2005年 / 40卷
关键词：
Public Health; Hepatitis; Internal Medicine; Interferon; Combine Effect;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：215 / 216
页数：1
相关论文
共 50 条
  • [1] Combined effect of an ACE inhibitor, perindopril, and interferon on liver fibrosis markers in patients with chronic hepatitis C
    Yoshiji, H
    Noguchi, R
    Fukui, H
    [J]. JOURNAL OF GASTROENTEROLOGY, 2005, 40 (02) : 215 - 216
  • [2] Evaluation of liver fibrosis by combined serum markers in chronic hepatitis C patients treated by interferon alpha and ribavrin
    Leroy, V
    Trocme, C
    Bottari, S
    Sturm, N
    Morel, F
    Zarski, JP
    [J]. JOURNAL OF HEPATOLOGY, 2002, 36 : 116 - 116
  • [3] Effect of interferon alfa on serum markers for hepatic fibrosis in patients with chronic hepatitis C
    Suou, T
    Hosho, K
    Okano, J
    Shiota, G
    Yamamoto, T
    Kawasaki, H
    [J]. HEPATOLOGY, 1996, 23 (01) : P246 - P246
  • [4] Interferon improves liver fibrosis in patients with chronic hepatitis C
    Serejo, F
    Costa, A
    Ramalho, F
    Batista, A
    Moura, MC
    [J]. JOURNAL OF HEPATOLOGY, 2000, 32 : 181 - 181
  • [5] Evaluation of serum markers of liver fibrosis in chronic hepatitis C patients
    Sampson, E. L.
    Parkes, J.
    Ryder, S.
    Harris, S.
    Petry, C.
    Anderson-Mauser, L.
    Vajdi, M.
    Rosenberg, W.
    [J]. CLINICAL CHEMISTRY, 2006, 52 (06) : A47 - A48
  • [6] α-Interferon Improves Liver Fibrosis in Chronic Hepatitis C
    Fátima Serejo
    Adilia Costa
    A. Gouveia Oliveira
    Fernando Ramalho
    Amélia Batista
    Miguel Carneiro De Moura
    [J]. Digestive Diseases and Sciences, 2001, 46 (8) : 1684 - 1689
  • [7] Effect of interferon and ribavirin on progression of liver fibrosis in patients with severe chronic hepatitis C.
    Abergel, A
    Bonny, C
    Ughetto, S
    Darcha, C
    Chevalier, M
    Henquell, C
    Martineau, N
    Randl, K
    Lafeuille, H
    Aubiet-Cuvelier, B
    Bommelaer, G
    [J]. HEPATOLOGY, 2001, 34 (04) : 328A - 328A
  • [8] Evaluation of liver fibrosis serum markers in chronic hepatitis C patients.
    Figueiredo-Mendes, CG
    Martins, JR
    Nader, H
    Passerotti, C
    Alvariz, R
    Silva, IS
    Lanzoni, V
    Parise, E
    Silva, AE
    Ferraz, MLG
    [J]. HEPATOLOGY, 2002, 36 (04) : 557A - 557A
  • [9] Prediction of Liver Fibrosis in Patients with Chronic Hepatitis C by Biochemical Surrogate Markers
    Mehdi, Muzzafar
    Mugheri, Ali Hyder
    Kumar, Mahesh
    Zaidi, Asif Raza
    Khan, Wali
    Alam, Altaf
    [J]. PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (01): : 36 - 39
  • [10] The predictive value of noninvasive serum markers of liver fibrosis in patients with chronic hepatitis C
    Gokcan, Hale
    Kuzu, Ufuk Baris
    Oztas, Erkin
    Saygili, Fatih
    Oztuna, Derya
    Suna, Nuretdin
    Tenlik, Ilyas
    Akdogan, Meral
    Kacar, Sabite
    Kilic, Zeki Mesut Yalin
    Kayacetin, Ertugrul
    [J]. TURKISH JOURNAL OF GASTROENTEROLOGY, 2016, 27 (02): : 156 - 164
12345